Cantor Fitzgerald Maintains Overweight on Sol Strategies, Lowers Price Target to $1.7
Cantor Fitzgerald analyst Gareth Gacetta maintains Sol Strategies (NASDAQ: STKE ) with a Overweight and lowers the price target from $2 to $1.7.
Cantor Fitzgerald analyst Gareth Gacetta maintains Sol Strategies (NASDAQ: STKE ) with a Overweight and lowers the price target from $2 to $1.7.